Progyny Inc.

21.88
-0.43 (-1.93%)
At close: Mar 28, 2025, 3:59 PM
22.31
1.97%
After-hours: Mar 28, 2025, 04:51 PM EDT

Company Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.

Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.

In addition, it provides surrogacy and adoption reimbursement programs for employers.

The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015.

Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny Inc.
Progyny Inc. logo
Country United States
IPO Date Oct 25, 2019
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 675
CEO Peter Anevski CPA

Contact Details

Address:
1359 Broadway
New York, New York
United States
Website https://www.progyny.com

Stock Details

Ticker Symbol PGNY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001551306
CUSIP Number 74340E103
ISIN Number US74340E1038
Employer ID 27-2220139
SIC Code 8090

Key Executives

Name Position
Peter Anevski CPA Chief Executive Officer & Director
Mark S. Livingston CPA Chief Financial Officer
Risa Fisher Chief Marketing Officer
Steven Leist Chief Technology Officer
Allison Swartz Executive Vice President, General Counsel & Secretary
Cassandra Pratt Chief Human Resources Officer
David J. Schlanger J.D. Executive Chairman
James Hart Vice President of Investor Relations
Julie Stadlbauer Chief Business Development Officer
Michael Sturmer President

Latest SEC Filings

Date Type Title
Mar 05, 2025 4 Filing
Mar 05, 2025 4 Filing
Mar 05, 2025 4 Filing
Mar 05, 2025 4 Filing
Mar 03, 2025 S-8 Filing
Mar 03, 2025 4 Filing
Mar 03, 2025 10-K Annual Report
Feb 28, 2025 4 Filing
Feb 28, 2025 4 Filing
Feb 28, 2025 8-K/A [Amend] Current Report